Literature DB >> 4536856

Electroretinographic responses following vitamin A therapy in A-beta-lipoproteinemia.

M A Sperling, D A Hiles, J S Kennerdell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4536856     DOI： 10.1016/0002-9394(72)90063-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  7 in total

1.  Plasma vitamin A and beta-carotene in retinitis pigmentosa.

Authors:  W H Massoud; A C Bird; E S Perkins
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

Review 2.  Ophthaproblem. Vitamin A and vitamin E.

Authors:  Shaun Segal; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

3.  Mathematical models of retinitis pigmentosa: a study of the rate of progress in the different genetic forms.

Authors:  J T Pearlman
Journal:  Trans Am Ophthalmol Soc       Date:  1979

4.  Long-term management of abetalipoproteinaemia. Possible role for vitamin E.

Authors:  D P Muller; J K Lloyd; A C Bird
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

5.  Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.

Authors:  S Bishara; S Merin; M Cooper; E Azizi; G Delpre; R J Deckelbaum
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

6.  Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.

Authors:  P Runge; D P Muller; J McAllister; D Calver; J K Lloyd; D Taylor
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

7.  A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis.

Authors:  H J Willison; D P Muller; S Matthews; S Jones; A Kriss; R J Stead; M E Hodson; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.